Introducing Medisca Nutraceuticals

Download in electronic PDF format for $25



Search the Complete Journal Archives

Testing the Long-Term Stability of Vancomycin Ophthalmic Solution

Author(s):  McLellan Christine, Ngo Van, Pasedis Sophia, Dohlman Claes H

Issue:  Sep/Oct 2008 - Veterinary Compounding
View All Articles in Issue

Abstract:  Some patients with a keratoprosthesis (artificial cornea) are required to use prophylactic vancomycin ophthalmic solution daily for life to prevent infection, a regimen which has proven to be highly successful. The objective of this study was to determine whether such vancomycin solutions would remain stable at room temperature for an extended period of time, beyond that suggested by available published stability data and used in current practice. By relaxing the storage requirement and extending the expiration date of this solution, it was hoped that patient adherence and satisfaction would increase. The studied vancomycin ophthalmic solutions were compounded at the Massachusetts Eye and Ear Infirmary, Department of Pharmacy Services, Boston, Massachusetts, and were sent to an outside laboratory for high-performance liquid chromatography potency testing at predefined time points. Vancomycin 14-mg/mL ophthalmic solution compounded with 0.005% benzalkonium retains potency for at least 60 days at room temperatu

Related Keywords: Christine McLellan, PharmD, RPh, Van Ngo, BS, RPh, Sophia Pasedis, BS, PharmD, RPh, Claes H. Dohlman, MD, PhD, vancomycin, antimicrobial agent, antibiotic, eye disorders, ocular infection, corneal opacity, corneal transplant, keratoprosthesis, complications, blindness, prevention, prophylaxis, bacterial endophthalmitis, benzalkonium chloride, preservative, stability, potency

Related Categories: OPHTHALMICS, PEER-REVIEWED, STABILITIES, COMPATIBILITIES, INFECTIOUS DISEASE, PREVENTIVE MEDICINE/WELLNESS

Printer-Friendly Version

Related Articles from IJPC
Title (Click for Abstract / Details) Author Issue Page View/Buy
Testing the Long-Term Stability of Vancomycin Ophthalmic Solution McLellan Christine, Ngo Van, Pasedis Sophia, Dohlman Claes H Sep/Oct 2008 456-459 Buy
Stability and In Vitro Toxicity of an Infliximab Eye Drop Formulation Robert Marie-Claude, Spurr-Michaud Sandra, Frenette Mathieu, Young David, Gipson Ilene K, Dohlman Claes H Sep/Oct 2014 418-426 Buy
Wetting and/or Solubilizing Agents, Featured Excipient: Allen Loyd V Jr Jul/Aug 2001 310 Buy
Rapid-Dissolve Technology: An Interview With Loyd V. Allen, Jr., PhD, RPh Allen Loyd V Jr Nov/Dec 2003 449-450 Buy
Compounding for Treatment of Equine Infectious Diseases: An Overview Bramwell Bethany L Nov/Dec 2011 450-457 Buy
Ronidazole in the Treatment of Trichomonad Infections in Cats Davidson Gigi S Nov/Dec 2006 434-435 Buy
Stability of Commercially Available Grape and Compounded Cherry Oral Vancomycin Preparations Stored in Syringes and Cups Kirk Loren, Lewis Paul, Luu Yao, Brown Stacy Mar/Apr 2016 159-163 Buy
Long-term Stability of Vancomycin Hydrochloride in Oral Solution: The Brand Name Versus a Generic Product Huvelle Sophie, Godet Marie, Hecq Jean-Daniel, Gillet Patricia, Jamart Jacques, Galanti Laurence M Jul/Aug 2016 347-350 Buy
Long-term Stability of Vancomycin Hydrochloride in Glucose 5% Polyolefin Bags: The Brand Name Versus a Generic Product Huvelle Sophie, Godet Marie, Hecq Jean-Daniel, Gillet Patricia, Jamart Jacques, Galanti Laurence M Sep/Oct 2016 416-420 Buy
Autologous Eye Drops for the Treatment of Dry Eye and Neurotrophic Keratitis Mixon William, Angelle Patricea (Patsy), Chang Richard I Nov/Dec 2009 506-515 Buy